United States — Food and Drug Administration & Medscape
2 shared events · Importance 3 · Last updated Sep 02, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
United States — Food and Drug Administration: The FDA's July 27, 2026 briefing documents and July 29 advisory committee meeting triggered the stock collapse underlying the lawsuit, and its extension of the Deramiocel PDUFA date to November 22, 2026 keeps the review active.
Medscape: Medscape reported the advisory committee's 9-3 vote that available evidence did not support efficacy of Deramiocel, which triggered a further 36% stock decline.
Aug 10, 2026 · 267 articles
Regulatory
United States — Food and Drug Administration: Regulator whose briefing documents and advisory committee vote triggered the stock collapse and legal actions.
Medscape: Reported on the advisory committee vote, providing details on the 9-3 decision.
Jul 27, 2026 · 305 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — Food and Drug Administration and Medscape interact across events, view sentiment trends, and discover connected entities.
Open Dashboard